Crossroads C&I Completes Buy of Toronto-Based GlassCell Isofab
Crossroads C&I, which is backed by Distribution International Co., said Friday that it has closed its acquisition of GlassCell Isofab Inc.. No financial terms were disclosed. Headquartered in Toronto, GlassCell Isofab is a distributor and maker of thermal and acoustical insulation products. Houston, Texas-based Distribution International is a portfolio company of Audax Private Equity and The CapStreet Group. Update: Crossroads C&I was in sold to Distribution International by Canadian private equity firm Yellow Point Equity Partners in July 2012.





